BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paterna JC, Moccetti T, Mura A, Feldon J, Büeler H. Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain. Gene Ther. 2000;7:1304-1311. [PMID: 10918501 DOI: 10.1038/sj.gt.3301221] [Cited by in Crossref: 132] [Cited by in F6Publishing: 121] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Dayton RD, Wang DB, Cain CD, Schrott LM, Ramirez JJ, King MA, Klein RL. Frontotemporal lobar degeneration-related proteins induce only subtle memory-related deficits when bilaterally overexpressed in the dorsal hippocampus. Exp Neurol 2012;233:807-14. [PMID: 22177996 DOI: 10.1016/j.expneurol.2011.12.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
2 Klein RL, King MA, Hamby ME, Meyer EM. Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra. Hum Gene Ther 2002;13:605-12. [PMID: 11916484 DOI: 10.1089/10430340252837206] [Cited by in Crossref: 149] [Cited by in F6Publishing: 144] [Article Influence: 7.8] [Reference Citation Analysis]
3 Lee YB, Cosgrave AS, Glover CP, Bienemann A, Heywood D, Hobson RJ, Uney JB. Increased utility in the CNS of a powerful neuron-specific tetracycline-regulatable adenoviral system developed using a post-transcriptional enhancer. J Gene Med 2005;7:576-83. [PMID: 15580589 DOI: 10.1002/jgm.694] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
4 Isenmann S, Schmeer C, Kretz A. How to keep injured CNS neurons viable—strategies for neuroprotection and gene transfer to retinal ganglion cells. Molecular and Cellular Neuroscience 2004;26:1-16. [DOI: 10.1016/j.mcn.2004.01.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
5 Pocock GM, Zimdars LL, Yuan M, Eliceiri KW, Ahlquist P, Sherer NM. Diverse activities of viral cis-acting RNA regulatory elements revealed using multicolor, long-term, single-cell imaging. Mol Biol Cell 2017;28:476-87. [PMID: 27903772 DOI: 10.1091/mbc.E16-08-0612] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
6 Sohn J, Takahashi M, Okamoto S, Ishida Y, Furuta T, Hioki H. A Single Vector Platform for High-Level Gene Transduction of Central Neurons: Adeno-Associated Virus Vector Equipped with the Tet-Off System. PLoS One 2017;12:e0169611. [PMID: 28060929 DOI: 10.1371/journal.pone.0169611] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
7 Lehtonen E, Bonnaud F, Melas C, Lubansu A, Malgrange B, Chtarto A, Velu T, Brotchi J, Levivier M, Peschanski M, Tenenbaum L. AAV2 vectors mediate efficient and sustained transduction of rat embryonic ventral mesencephalon. Neuroreport 2002;13:1503-7. [PMID: 12218694 DOI: 10.1097/00001756-200208270-00003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Brown BD, Lillicrap D. Dangerous liaisons: the role of “danger” signals in the immune response to gene therapy. Blood 2002;100:1133-40. [DOI: 10.1182/blood-2001-11-0067] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 3.7] [Reference Citation Analysis]
9 Weltner J, Anisimov A, Alitalo K, Otonkoski T, Trokovic R. Induced pluripotent stem cell clones reprogrammed via recombinant adeno-associated virus-mediated transduction contain integrated vector sequences. J Virol 2012;86:4463-7. [PMID: 22301147 DOI: 10.1128/JVI.06302-11] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
10 Pajusola K, Künnapuu J, Vuorikoski S, Soronen J, André H, Pereira T, Korpisalo P, Ylä-Herttuala S, Poellinger L, Alitalo K. Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. FASEB J 2005;19:1365-7. [PMID: 15958522 DOI: 10.1096/fj.05-3720fje] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 5.7] [Reference Citation Analysis]
11 Fukuchi K, Tahara K, Kim HD, Maxwell JA, Lewis TL, Accavitti-Loper MA, Kim H, Ponnazhagan S, Lalonde R. Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease. Neurobiol Dis 2006;23:502-11. [PMID: 16766200 DOI: 10.1016/j.nbd.2006.04.012] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 4.6] [Reference Citation Analysis]
12 Patrício MI, Barnard AR, Orlans HO, McClements ME, MacLaren RE. Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina. Mol Ther Nucleic Acids 2017;6:198-208. [PMID: 28325286 DOI: 10.1016/j.omtn.2016.12.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
13 Mattar CN, Wong AM, Hoefer K, Alonso-Ferrero ME, Buckley SM, Howe SJ, Cooper JD, Waddington SN, Chan JK, Rahim AA. Systemic gene delivery following intravenous administration of AAV9 to fetal and neonatal mice and late-gestation nonhuman primates. FASEB J 2015;29:3876-88. [PMID: 26062602 DOI: 10.1096/fj.14-269092] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
14 Brown N, Song L, Kollu NR, Hirsch ML. Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes? Hum Gene Ther 2017;28:450-63. [PMID: 28490211 DOI: 10.1089/hum.2017.038] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
15 Schwenter F, Déglon N, Aebischer P. Optimization of human erythropoietin secretion from MLV-infected human primary fibroblasts used for encapsulated cell therapy: Epo Secretion from Encapsulated Human Fibroblasts. J Gene Med 2003;5:246-57. [DOI: 10.1002/jgm.338] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
16 Keränen MA, Nykänen AI, Krebs R, Pajusola K, Tuuminen R, Alitalo K, Lemström KB. Cardiomyocyte-targeted HIF-1α gene therapy inhibits cardiomyocyte apoptosis and cardiac allograft vasculopathy in the rat. The Journal of Heart and Lung Transplantation 2010;29:1058-66. [DOI: 10.1016/j.healun.2010.05.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
17 Nomoto T, Okada T, Shimazaki K, Mizukami H, Matsushita T, Hanazono Y, Kume A, Katsura K, Katayama Y, Ozawa K. Distinct patterns of gene transfer to gerbil hippocampus with recombinant adeno-associated virus type 2 and 5. Neurosci Lett 2003;340:153-7. [PMID: 12668259 DOI: 10.1016/s0304-3940(03)00095-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
18 Bantounas I, Glover CP, Kelly S, Iseki S, Phylactou LA, Uney JB. Assessing adenoviral hammerhead ribozyme and small hairpin RNA cassettes in neurons: Inhibition of endogenous caspase-3 activity and protection from apoptotic cell death. J Neurosci Res 2005;79:661-9. [DOI: 10.1002/jnr.20389] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
19 Kügler S, Lingor P, Schöll U, Zolotukhin S, Bähr M. Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units. Virology 2003;311:89-95. [PMID: 12832206 DOI: 10.1016/s0042-6822(03)00162-4] [Cited by in Crossref: 93] [Cited by in F6Publishing: 41] [Article Influence: 5.2] [Reference Citation Analysis]
20 Burger C, Nash K, Mandel RJ. Recombinant adeno-associated viral vectors in the nervous system. Hum Gene Ther 2005;16:781-91. [PMID: 16000060 DOI: 10.1089/hum.2005.16.781] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 5.1] [Reference Citation Analysis]
21 Monory K, Massa F, Egertová M, Eder M, Blaudzun H, Westenbroek R, Kelsch W, Jacob W, Marsch R, Ekker M, Long J, Rubenstein JL, Goebbels S, Nave KA, During M, Klugmann M, Wölfel B, Dodt HU, Zieglgänsberger W, Wotjak CT, Mackie K, Elphick MR, Marsicano G, Lutz B. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 2006;51:455-66. [PMID: 16908411 DOI: 10.1016/j.neuron.2006.07.006] [Cited by in Crossref: 450] [Cited by in F6Publishing: 459] [Article Influence: 30.0] [Reference Citation Analysis]
22 Siman R, Lin YG, Malthankar-Phatak G, Dong Y. A rapid gene delivery-based mouse model for early-stage Alzheimer disease-type tauopathy. J Neuropathol Exp Neurol 2013;72:1062-71. [PMID: 24128676 DOI: 10.1097/NEN.0000000000000006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
23 Jiang D, Lee H, Pardridge WM. Plasmid DNA gene therapy of the Niemann-Pick C1 mouse with transferrin receptor-targeted Trojan horse liposomes. Sci Rep 2020;10:13334. [PMID: 32770132 DOI: 10.1038/s41598-020-70290-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
24 Castle MJ, Turunen HT, Vandenberghe LH, Wolfe JH. Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids. Methods Mol Biol 2016;1382:133-49. [PMID: 26611584 DOI: 10.1007/978-1-4939-3271-9_10] [Cited by in Crossref: 64] [Cited by in F6Publishing: 47] [Article Influence: 12.8] [Reference Citation Analysis]
25 Paterna J, Büeler H. Recombinant adeno-associated virus vector design and gene expression in the mammalian brain. Methods 2002;28:208-18. [DOI: 10.1016/s1046-2023(02)00225-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
26 Haery L, Deverman BE, Matho KS, Cetin A, Woodard K, Cepko C, Guerin KI, Rego MA, Ersing I, Bachle SM, Kamens J, Fan M. Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation. Front Neuroanat 2019;13:93. [PMID: 31849618 DOI: 10.3389/fnana.2019.00093] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 15.0] [Reference Citation Analysis]
27 Fitzsimons HL, Bland RJ, During MJ. Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain. Methods 2002;28:227-36. [DOI: 10.1016/s1046-2023(02)00227-x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
28 Li PY, Yu L, Wu XA, Bai WT, Li K, Wang HT, Hu G, Zhang L, Zhang FL, Xu ZK. Modification of the adenoviral transfer vector enhances expression of the Hantavirus fusion protein GnS0.7 and induces a strong immune response in C57BL/6 mice. J Virol Methods 2012;179:90-6. [PMID: 22015676 DOI: 10.1016/j.jviromet.2011.10.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
29 Bell P, Wang L, Chen SJ, Yu H, Zhu Y, Nayal M, He Z, White J, Lebel-Hagan D, Wilson JM. Effects of Self-Complementarity, Codon Optimization, Transgene, and Dose on Liver Transduction with AAV8. Hum Gene Ther Methods 2016;27:228-37. [PMID: 27903094 DOI: 10.1089/hgtb.2016.039] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
30 Paterna JC, Feldon J, Büeler H. Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats. J Virol 2004;78:6808-17. [PMID: 15194756 DOI: 10.1128/JVI.78.13.6808-6817.2004] [Cited by in Crossref: 70] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
31 Klugmann M, Szumlinski KK. Targeting Homer genes using adeno-associated viral vector: lessons learned from behavioural and neurochemical studies. Behav Pharmacol 2008;19:485-500. [PMID: 18690104 DOI: 10.1097/FBP.0b013e32830c369f] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
32 Smith SN, Paige C, Velazquez KT, Smith TP, Raja SN, Wilson SP, Sweitzer SM. Injury-specific promoters enhance herpes simplex virus-mediated gene therapy for treating neuropathic pain in rodents. J Pain 2015;16:283-90. [PMID: 25576797 DOI: 10.1016/j.jpain.2014.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Hope T. Improving the post-transcriptional aspects of lentiviral vectors. Curr Top Microbiol Immunol 2002;261:179-89. [PMID: 11892247 DOI: 10.1007/978-3-642-56114-6_9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
34 Pertl U, Wodrich H, Ruehlmann JM, Gillies SD, Lode HN, Reisfeld RA. Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma. Blood 2003;101:649-54. [DOI: 10.1182/blood-2002-02-0391] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
35 Saaristo A, Veikkola T, Enholm B, Hytönen M, Arola J, Pajusola K, Turunen P, Jeltsch M, Karkkainen MJ, Kerjaschki D, Bueler H, Yla‐herttuala S, Alitalo K. Adenoviral VEGF‐C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB j 2002;16:1041-9. [DOI: 10.1096/fj.01-1042com] [Cited by in Crossref: 125] [Cited by in F6Publishing: 108] [Article Influence: 6.6] [Reference Citation Analysis]
36 Challis RC, Ravindra Kumar S, Chan KY, Challis C, Beadle K, Jang MJ, Kim HM, Rajendran PS, Tompkins JD, Shivkumar K, Deverman BE, Gradinaru V. Systemic AAV vectors for widespread and targeted gene delivery in rodents. Nat Protoc 2019;14:379-414. [PMID: 30626963 DOI: 10.1038/s41596-018-0097-3] [Cited by in Crossref: 76] [Cited by in F6Publishing: 58] [Article Influence: 38.0] [Reference Citation Analysis]
37 Keskitalo S, Tammela T, Lyytikka J, Karpanen T, Jeltsch M, Markkanen J, Yla-Herttuala S, Alitalo K. Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein. Circ Res 2007;100:1460-7. [PMID: 17478734 DOI: 10.1161/01.RES.0000269042.58594.f6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
38 Glover CP, Bienemann AS, Heywood DJ, Cosgrave A, Uney JB. Adenoviral-Mediated, High-Level, Cell-Specific Transgene Expression: A SYN1-WPRE Cassette Mediates Increased Transgene Expression with No Loss of Neuron Specificity. Molecular Therapy 2002;5:509-16. [DOI: 10.1006/mthe.2002.0588] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 4.5] [Reference Citation Analysis]
39 Han Y, Chang QA, Virag T, West NC, George D, Castro MG, Bohn MC. Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors. Gene Ther 2010;17:616-25. [PMID: 20164859 DOI: 10.1038/gt.2010.6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
40 Mudannayake JM, Mouravlev A, Fong DM, Young D. Transcriptional activity of novel ALDH1L1 promoters in the rat brain following AAV vector-mediated gene transfer. Mol Ther Methods Clin Dev 2016;3:16075. [PMID: 27990448 DOI: 10.1038/mtm.2016.75] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
41 Cotugno G, Annunziata P, Barone MV, Karali M, Banfi S, Auricchio A. Impact of age at administration, lysosomal storage, and transgene regulatory elements on AAV2/8-mediated rat liver transduction. PLoS One 2012;7:e33286. [PMID: 22428010 DOI: 10.1371/journal.pone.0033286] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
42 Furler S, Paterna J, Weibel M, Büeler H. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons. Gene Ther 2001;8:864-73. [DOI: 10.1038/sj.gt.3301469] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
43 Zulliger R, Conley SM, Naash MI. Non-viral therapeutic approaches to ocular diseases: An overview and future directions. J Control Release 2015;219:471-87. [PMID: 26439665 DOI: 10.1016/j.jconrel.2015.10.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
44 Alonso A, Reinz E, Leuchs B, Kleinschmidt J, Fatar M, Geers B, Lentacker I, Hennerici MG, de Smedt SC, Meairs S. Focal Delivery of AAV2/1-transgenes Into the Rat Brain by Localized Ultrasound-induced BBB Opening. Mol Ther Nucleic Acids 2013;2:e73. [PMID: 23423361 DOI: 10.1038/mtna.2012.64] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
45 Esslinger CS, Agarwal S, Gerdes J, Wilson PA, Davis ES, Awes AN, O'Brien E, Mavencamp T, Koch HP, Poulsen DJ, Rhoderick JF, Chamberlin AR, Kavanaugh MP, Bridges RJ. The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3. Neuropharmacology 2005;49:850-61. [PMID: 16183084 DOI: 10.1016/j.neuropharm.2005.08.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
46 Blits B, Oudega M, Boer GJ, Bartlett Bunge M, Verhaagen J. Adeno-associated viral vector-mediated neurotrophin gene transfer in the injured adult rat spinal cord improves hind-limb function. Neuroscience 2003;118:271-81. [PMID: 12676157 DOI: 10.1016/s0306-4522(02)00970-3] [Cited by in Crossref: 86] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
47 Ostrowski LE, Hutchins JR, Zakel K, O'Neal WK. Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter. Mol Ther 2003;8:637-45. [PMID: 14529837 DOI: 10.1016/s1525-0016(03)00221-1] [Cited by in Crossref: 76] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
48 Royo NC, Vandenberghe LH, Ma JY, Hauspurg A, Yu L, Maronski M, Johnston J, Dichter MA, Wilson JM, Watson DJ. Specific AAV serotypes stably transduce primary hippocampal and cortical cultures with high efficiency and low toxicity. Brain Res 2008;1190:15-22. [PMID: 18054899 DOI: 10.1016/j.brainres.2007.11.015] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
49 Jha SK, Rauniyar K, Chronowska E, Mattonet K, Maina EW, Koistinen H, Stenman UH, Alitalo K, Jeltsch M. KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D. Elife 2019;8:e44478. [PMID: 31099754 DOI: 10.7554/eLife.44478] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
50 Embury JE, Charron CE, Martynyuk A, Zori AG, Liu B, Ali SF, Rowland NE, Laipis PJ. PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) mice. Brain Res 2007;1127:136-50. [PMID: 17112485 DOI: 10.1016/j.brainres.2006.09.101] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
51 Rahim AA, Wong AMS, Hoefer K, Buckley SMK, Mattar CN, Cheng SH, Chan JKY, Cooper JD, Waddington SN. Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system. FASEB j 2011;25:3505-18. [DOI: 10.1096/fj.11-182311] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 7.0] [Reference Citation Analysis]
52 Ding Z, Georgiev P, Thöny B. Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer. Gene Ther 2006;13:587-93. [PMID: 16319947 DOI: 10.1038/sj.gt.3302684] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 3.8] [Reference Citation Analysis]
53 Unger MD, Pleticha J, Heilmann LF, Newman LK, Maus TP, Beutler AS. Human interleukin-10 delivered intrathecally by self-complementary adeno-associated virus 8 induces xenogeneic transgene immunity without clinical neurotoxicity in swine. J Gene Med 2018;20:e3026. [PMID: 29800509 DOI: 10.1002/jgm.3026] [Reference Citation Analysis]
54 Dreismann AK, McClements ME, Barnard AR, Orhan E, Hughes JP, Lachmann PJ, MacLaren RE. Functional expression of complement factor I following AAV-mediated gene delivery in the retina of mice and human cells. Gene Ther 2021;28:265-76. [PMID: 33750925 DOI: 10.1038/s41434-021-00239-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Washbourne P, McAllister AK. Techniques for gene transfer into neurons. Curr Opin Neurobiol 2002;12:566-73. [PMID: 12367637 DOI: 10.1016/s0959-4388(02)00365-3] [Cited by in Crossref: 131] [Cited by in F6Publishing: 41] [Article Influence: 6.9] [Reference Citation Analysis]
56 Johansen J, Tornøe J, Møller A, Johansen TE. Increased in vitro and in vivo transgene expression levels mediated through cis -acting elements: Cis Elements Increased Ex Vivo Gene Expression. J Gene Med 2003;5:1080-9. [DOI: 10.1002/jgm.444] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
57 Fuller-Carter PI, Basiri H, Harvey AR, Carvalho LS. Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration. BioDrugs 2020;34:763-81. [PMID: 33136237 DOI: 10.1007/s40259-020-00453-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
58 Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A. 2001;98:12677-12682. [PMID: 11592985 DOI: 10.1073/pnas.221449198] [Cited by in Crossref: 415] [Cited by in F6Publishing: 364] [Article Influence: 20.8] [Reference Citation Analysis]
59 Wong ET, Kolman JL, Li YC, Mesner LD, Hillen W, Berens C, Wahl GM. Reproducible doxycycline-inducible transgene expression at specific loci generated by Cre-recombinase mediated cassette exchange. Nucleic Acids Res 2005;33:e147. [PMID: 16204450 DOI: 10.1093/nar/gni145] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
60 Bockstael O, Chtarto A, Wakkinen J, Yang X, Melas C, Levivier M, Brotchi J, Tenenbaum L. Differential transgene expression profiles in rat brain, using rAAV2/1 vectors with tetracycline-inducible and cytomegalovirus promoters. Hum Gene Ther 2008;19:1293-305. [PMID: 19866492 DOI: 10.1089/hum.2008.099] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
61 Nair HP, Young LJ. Application of adeno-associated viral vectors in behavioral research. Methods 2002;28:195-202. [DOI: 10.1016/s1046-2023(02)00223-2] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
62 de Silva SR, Mcclements ME, Hankins MW, Maclaren RE. Adeno-Associated Viral Gene Therapy for Retinal Disorders. In: Bo X, Verhaagen J, editors. Gene Delivery and Therapy for Neurological Disorders. New York: Springer; 2015. pp. 203-28. [DOI: 10.1007/978-1-4939-2306-9_9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
63 De Ravin SS, Brault J. CRISPR/Cas9 applications in gene therapy for primary immunodeficiency diseases. Emerg Top Life Sci 2019;3:277-87. [PMID: 33523134 DOI: 10.1042/ETLS20180157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
64 Boulaire J, Balani P, Wang S. Transcriptional targeting to brain cells: Engineering cell type-specific promoter containing cassettes for enhanced transgene expression. Advanced Drug Delivery Reviews 2009;61:589-602. [DOI: 10.1016/j.addr.2009.02.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
65 Sulg M, Kirjavainen A, Pajusola K, Bueler H, Ylikoski J, Laiho M, Pirvola U. Differential sensitivity of the inner ear sensory cell populations to forced cell cycle re-entry and p53 induction. J Neurochem. 2010;112:1513-1526. [PMID: 20050971 DOI: 10.1111/j.1471-4159.2009.06563.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
66 Robciuc MR, Skrobuk P, Anisimov A, Olkkonen VM, Alitalo K, Eckel RH, Koistinen HA, Jauhiainen M, Ehnholm C. Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes. PLoS One 2012;7:e46212. [PMID: 23056264 DOI: 10.1371/journal.pone.0046212] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
67 Smith KL, Gardiner JV, Ward HL, Kong WM, Murphy KG, Martin NM, Ghatei MA, Bloom SR. Overexpression of CART in the PVN Increases Food Intake and Weight Gain in Rats. Obesity 2008;16:2239-44. [DOI: 10.1038/oby.2008.366] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
68 Ruitenberg MJ, Blits B, Dijkhuizen PA, te Beek ET, Bakker A, van Heerikhuize JJ, Pool CW, Hermens WT, Boer GJ, Verhaagen J. Adeno-associated viral vector-mediated gene transfer of brain-derived neurotrophic factor reverses atrophy of rubrospinal neurons following both acute and chronic spinal cord injury. Neurobiol Dis 2004;15:394-406. [PMID: 15006710 DOI: 10.1016/j.nbd.2003.11.018] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
69 Martin KR, Klein RL, Quigley HA. Gene delivery to the eye using adeno-associated viral vectors. Methods 2002;28:267-75. [PMID: 12413426 DOI: 10.1016/s1046-2023(02)00232-3] [Cited by in Crossref: 104] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
70 Wang L, Wang H, Morizono H, Bell P, Jones D, Lin J, McMenamin D, Yu H, Batshaw ML, Wilson JM. Sustained correction of OTC deficiency in spf( ash) mice using optimized self-complementary AAV2/8 vectors. Gene Ther 2012;19:404-10. [PMID: 21850052 DOI: 10.1038/gt.2011.111] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
71 Borodinova AA, Balaban PM, Bezprozvanny IB, Salmina AB, Vlasova OL. Genetic Constructs for the Control of Astrocytes' Activity. Cells 2021;10:1600. [PMID: 34202359 DOI: 10.3390/cells10071600] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Pietola L. Effects of p27 Kip1 - and p53- shRNAs on kanamycin damaged mouse cochlea. WJO 2012;2:1. [DOI: 10.5319/wjo.v2.i1.1] [Reference Citation Analysis]
73 Klaus F, Paterna J, Marzorati E, Sigrist H, Götze L, Schwendener S, Bergamini G, Jehli E, Azzinnari D, Fuertig R, Fontana A, Seifritz E, Pryce CR. Differential effects of peripheral and brain tumor necrosis factor on inflammation, sickness, emotional behavior and memory in mice. Brain, Behavior, and Immunity 2016;58:310-26. [DOI: 10.1016/j.bbi.2016.08.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
74 Liu Y, Keefe K, Tang X, Lin S, Smith GM. Use of self-complementary adeno-associated virus serotype 2 as a tracer for labeling axons: implications for axon regeneration. PLoS One 2014;9:e87447. [PMID: 24498323 DOI: 10.1371/journal.pone.0087447] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
75 Holopainen T, Saharinen P, D'Amico G, Lampinen A, Eklund L, Sormunen R, Anisimov A, Zarkada G, Lohela M, Heloterä H, Tammela T, Benjamin LE, Ylä-Herttuala S, Leow CC, Koh GY, Alitalo K. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J Natl Cancer Inst 2012;104:461-75. [PMID: 22343031 DOI: 10.1093/jnci/djs009] [Cited by in Crossref: 143] [Cited by in F6Publishing: 120] [Article Influence: 15.9] [Reference Citation Analysis]
76 Strayer D, Branco F, Zern MA, Yam P, Calarota SA, Nichols CN, Zaia JA, Rossi J, Li H, Parashar B, Ghosh S, Chowdhury JR. Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors. Mol Ther 2002;6:227-37. [PMID: 12161189 DOI: 10.1006/mthe.2002.0657] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
77 Tolmachova T, Tolmachov OE, Barnard AR, de Silva SR, Lipinski DM, Walker NJ, Maclaren RE, Seabra MC. Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo. J Mol Med (Berl) 2013;91:825-37. [PMID: 23756766 DOI: 10.1007/s00109-013-1006-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
78 Cai D, Cohen KB, Luo T, Lichtman JW, Sanes JR. Improved tools for the Brainbow toolbox. Nat Methods 2013;10:540-7. [PMID: 23817127 DOI: 10.1038/nmeth.2450] [Cited by in Crossref: 262] [Cited by in F6Publishing: 197] [Article Influence: 32.8] [Reference Citation Analysis]
79 Barnard AR, Groppe M, MacLaren RE. Gene therapy for choroideremia using an adeno-associated viral (AAV) vector. Cold Spring Harb Perspect Med 2014;5:a017293. [PMID: 25359548 DOI: 10.1101/cshperspect.a017293] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
80 Klein R, Ruttkowski B, Knapp E, Salmons B, Günzburg WH, Hohenadl C. WPRE-mediated enhancement of gene expression is promoter and cell line specific. Gene 2006;372:153-61. [DOI: 10.1016/j.gene.2005.12.018] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
81 Lebesgue D, Reyna-Neyra A, Huang X, Etgen AM. GPR30 differentially regulates short latency responses of luteinising hormone and prolactin secretion to oestradiol. J Neuroendocrinol 2009;21:743-52. [PMID: 19523168 DOI: 10.1111/j.1365-2826.2009.01893.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
82 Orefice NS, Souchet B, Braudeau J, Alves S, Piguet F, Collaud F, Ronzitti G, Tada S, Hantraye P, Mingozzi F, Ducongé F, Cartier N. Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain. Mol Ther Methods Clin Dev 2019;14:237-51. [PMID: 31440523 DOI: 10.1016/j.omtm.2019.06.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
83 Dong Z, Ferger B, Paterna JC, Vogel D, Furler S, Osinde M, Feldon J, Büeler H. Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1. Proc Natl Acad Sci U S A 2003;100:12438-43. [PMID: 14530399 DOI: 10.1073/pnas.2132992100] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 4.8] [Reference Citation Analysis]
84 Leite de Oliveira R, Deschoemaeker S, Henze AT, Debackere K, Finisguerra V, Takeda Y, Roncal C, Dettori D, Tack E, Jönsson Y, Veschini L, Peeters A, Anisimov A, Hofmann M, Alitalo K, Baes M, D'hooge J, Carmeliet P, Mazzone M. Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity. Cancer Cell 2012;22:263-77. [PMID: 22897855 DOI: 10.1016/j.ccr.2012.06.028] [Cited by in Crossref: 89] [Cited by in F6Publishing: 78] [Article Influence: 9.9] [Reference Citation Analysis]
85 Fagoe ND, Eggers R, Verhaagen J, Mason MR. A compact dual promoter adeno-associated viral vector for efficient delivery of two genes to dorsal root ganglion neurons. Gene Ther 2014;21:242-52. [PMID: 24285216 DOI: 10.1038/gt.2013.71] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
86 Dong Z, Ferger B, Feldon J, Büeler H. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP. J Neurobiol 2002;53:1-10. [PMID: 12360578 DOI: 10.1002/neu.10094] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
87 Liu BH, Wang X, Ma YX, Wang S. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression. Gene Ther 2004;11:52-60. [PMID: 14681697 DOI: 10.1038/sj.gt.3302126] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
88 Wang CY, Guo HY, Lim TM, Ng YK, Neo HP, Hwang PY, Yee WC, Wang S. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter. J Gene Med 2005;7:945-55. [PMID: 15756650 DOI: 10.1002/jgm.742] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
89 Zeng J, Du J, Lin J, Bak XY, Wu C, Wang S. High-efficiency transient transduction of human embryonic stem cell-derived neurons with baculoviral vectors. Mol Ther 2009;17:1585-93. [PMID: 19532141 DOI: 10.1038/mt.2009.124] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
90 Pease ME, Zack DJ, Berlinicke C, Bloom K, Cone F, Wang Y, Klein RL, Hauswirth WW, Quigley HA. Effect of CNTF on retinal ganglion cell survival in experimental glaucoma. Invest Ophthalmol Vis Sci 2009;50:2194-200. [PMID: 19060281 DOI: 10.1167/iovs.08-3013] [Cited by in Crossref: 119] [Cited by in F6Publishing: 116] [Article Influence: 9.2] [Reference Citation Analysis]
91 Uutela M, Wirzenius M, Paavonen K, Rajantie I, He Y, Karpanen T, Lohela M, Wiig H, Salven P, Pajusola K, Eriksson U, Alitalo K. PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Blood 2004;104:3198-204. [PMID: 15271796 DOI: 10.1182/blood-2004-04-1485] [Cited by in Crossref: 107] [Cited by in F6Publishing: 94] [Article Influence: 6.3] [Reference Citation Analysis]
92 Soderblom C, Lee DH, Dawood A, Carballosa M, Jimena Santamaria A, Benavides FD, Jergova S, Grumbles RM, Thomas CK, Park KK, Guest JD, Lemmon VP, Lee JK, Tsoulfas P. 3D Imaging of Axons in Transparent Spinal Cords from Rodents and Nonhuman Primates. eNeuro 2015;2. [PMID: 26023683 DOI: 10.1523/ENEURO.0001-15.2015] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
93 Miao CH. A Novel Gene Expression System: Non‐Viral Gene Transfer for Hemophilia as Model Systems. Non-Viral Vectors for Gene Therapy, Second Edition: Part 2. Elsevier; 2005. pp. 143-77. [DOI: 10.1016/s0065-2660(05)54007-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
94 Eaton MJ, Blits B, Ruitenberg MJ, Verhaagen J, Oudega M. Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord. Gene Ther 2002;9:1387-95. [DOI: 10.1038/sj.gt.3301814] [Cited by in Crossref: 106] [Cited by in F6Publishing: 86] [Article Influence: 5.6] [Reference Citation Analysis]
95 Snyder BR, Gray SJ, Quach ET, Huang JW, Leung CH, Samulski RJ, Boulis NM, Federici T. Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery. Hum Gene Ther 2011;22:1129-35. [PMID: 21443428 DOI: 10.1089/hum.2011.008] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 10.0] [Reference Citation Analysis]
96 MacLaren RE. Gene therapy for age-related macular degeneration. Lancet 2015;386:2369-70. [PMID: 26431822 DOI: 10.1016/S0140-6736(15)00346-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
97 Buscara L, Gross DA, Daniele N. Of rAAV and Men: From Genetic Neuromuscular Disorder Efficacy and Toxicity Preclinical Studies to Clinical Trials and Back. J Pers Med 2020;10:E258. [PMID: 33260623 DOI: 10.3390/jpm10040258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Saaristo A, Veikkola T, Tammela T, Enholm B, Karkkainen MJ, Pajusola K, Bueler H, Ylä-Herttuala S, Alitalo K. Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med 2002;196:719-30. [PMID: 12235206 DOI: 10.1084/jem.20020587] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 5.8] [Reference Citation Analysis]
99 Ye R, Rhoderick JF, Thompson CM, Bridges RJ. Functional expression, purification and high sequence coverage mass spectrometric characterization of human excitatory amino acid transporter EAAT2. Protein Expr Purif 2010;74:49-59. [PMID: 20399272 DOI: 10.1016/j.pep.2010.04.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
100 Wu K, Meyer EM, Bennett JA, Meyers CA, Hughes JA, King MA. AAV2/5-mediated NGF gene delivery protects septal cholinergic neurons following axotomy. Brain Research 2005;1061:107-13. [DOI: 10.1016/j.brainres.2005.08.056] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
101 Gray SJ, Foti SB, Schwartz JW, Bachaboina L, Taylor-Blake B, Coleman J, Ehlers MD, Zylka MJ, McCown TJ, Samulski RJ. Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. Hum Gene Ther 2011;22:1143-53. [PMID: 21476867 DOI: 10.1089/hum.2010.245] [Cited by in Crossref: 180] [Cited by in F6Publishing: 160] [Article Influence: 18.0] [Reference Citation Analysis]
102 Shevtsova Z, Malik JM, Michel U, Bähr M, Kügler S. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo. Exp Physiol. 2005;90:53-59. [PMID: 15542619 DOI: 10.1113/expphysiol.2004.028159] [Cited by in Crossref: 144] [Cited by in F6Publishing: 133] [Article Influence: 8.5] [Reference Citation Analysis]
103 Choi JH, Yu NK, Baek GC, Bakes J, Seo D, Nam HJ, Baek SH, Lim CS, Lee YS, Kaang BK. Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons. Mol Brain 2014;7:17. [PMID: 24618276 DOI: 10.1186/1756-6606-7-17] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 9.0] [Reference Citation Analysis]
104 [DOI: 10.1101/246405] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Pajusola K, Gruchala M, Joch H, Lüscher TF, Ylä-Herttuala S, Büeler H. Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells. J Virol 2002;76:11530-40. [PMID: 12388714 DOI: 10.1128/jvi.76.22.11530-11540.2002] [Cited by in Crossref: 75] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
106 Düring DN, Dittrich F, Rocha MD, Tachibana RO, Mori C, Okanoya K, Boehringer R, Ehret B, Grewe BF, Gerber S, Ma S, Rauch M, Paterna JC, Kasper R, Gahr M, Hahnloser RHR. Fast Retrograde Access to Projection Neuron Circuits Underlying Vocal Learning in Songbirds. Cell Rep 2020;33:108364. [PMID: 33176132 DOI: 10.1016/j.celrep.2020.108364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
107 Maturana CJ, Verpeut JL, Pisano TJ, Dhanerawala ZM, Esteves A, Enquist LW, Engel EA. Small Alphaherpesvirus Latency-Associated Promoters Drive Efficient and Long-Term Transgene Expression in the CNS. Mol Ther Methods Clin Dev 2020;17:843-57. [PMID: 32368565 DOI: 10.1016/j.omtm.2020.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
108 Nykänen AI, Pajusola K, Krebs R, Keränen MA, Raisky O, Koskinen PK, Alitalo K, Lemström KB. Common Protective and Diverse Smooth Muscle Cell Effects of AAV-Mediated Angiopoietin-1 and -2 Expression in Rat Cardiac Allograft Vasculopathy. Circulation Research 2006;98:1373-80. [DOI: 10.1161/01.res.0000225987.52765.13] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
109 Pietropaolo S, Paterna J, Büeler H, Feldon J, Yee BK. Bidirectional changes in water-maze learning following recombinant adenovirus-associated viral vector (rAAV)-mediated brain-derived neurotrophic factor expression in the rat hippocampus. Behavioural Pharmacology 2007;18:533-47. [DOI: 10.1097/fbp.0b013e3282da0bf6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
110 Gaál EI, Tammela T, Anisimov A, Marbacher S, Honkanen P, Zarkada G, Leppänen VM, Tatlisumak T, Hernesniemi J, Niemelä M, Alitalo K. Comparison of vascular growth factors in the murine brain reveals placenta growth factor as prime candidate for CNS revascularization. Blood 2013;122:658-65. [PMID: 23803710 DOI: 10.1182/blood-2012-07-441527] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
111 Jalkanen J, Leppänen P, Pajusola K, Närvänen O, Mähönen A, Vähäkangas E, Greaves DR, Büeler H, Ylä-herttuala S. Adeno-associated virus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor reduces atherosclerotic lesion formation in LDL receptor knockout mice. Molecular Therapy 2003;8:903-10. [DOI: 10.1016/j.ymthe.2003.09.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
112 Nieuwenhuis B, Haenzi B, Hilton S, Carnicer-Lombarte A, Hobo B, Verhaagen J, Fawcett JW. Optimization of adeno-associated viral vector-mediated transduction of the corticospinal tract: comparison of four promoters. Gene Ther 2021;28:56-74. [PMID: 32576975 DOI: 10.1038/s41434-020-0169-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
113 de Almeida L, Zala D, Aebischer P, Déglon N. Neuroprotective Effect of a CNTF-Expressing Lentiviral Vector in the Quinolinic Acid Rat Model of Huntington's Disease. Neurobiology of Disease 2001;8:433-46. [DOI: 10.1006/nbdi.2001.0388] [Cited by in Crossref: 107] [Cited by in F6Publishing: 100] [Article Influence: 5.4] [Reference Citation Analysis]
114 Xu Z, Mizuguchi H, Mayumi T, Hayakawa T. Woodchuck hepatitis virus post-transcriptional regulation element enhances transgene expression from adenovirus vectors. Biochimica et Biophysica Acta (BBA) - General Subjects 2003;1621:266-71. [DOI: 10.1016/s0304-4165(03)00078-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
115 Klein RL, Hamby ME, Gong Y, Hirko AC, Wang S, Hughes JA, King MA, Meyer EM. Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain. Exp Neurol 2002;176:66-74. [PMID: 12093083 DOI: 10.1006/exnr.2002.7942] [Cited by in Crossref: 114] [Cited by in F6Publishing: 107] [Article Influence: 6.0] [Reference Citation Analysis]
116 Crystal RG, Sondhi D, Hackett NR, Kaminsky SM, Worgall S, Stieg P, Souweidane M, Hosain S, Heier L, Ballon D, Dinner M, Wisniewski K, Kaplitt M, Greenwald BM, Howell JD, Strybing K, Dyke J, Voss H. Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis. Hum Gene Ther 2004;15:1131-54. [PMID: 15610613 DOI: 10.1089/hum.2004.15.1131] [Cited by in Crossref: 96] [Cited by in F6Publishing: 81] [Article Influence: 6.0] [Reference Citation Analysis]
117 Paterna JC, Leng A, Weber E, Feldon J, Büeler H. DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol Ther 2007;15:698-704. [PMID: 17299411 DOI: 10.1038/sj.mt.6300067] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 3.6] [Reference Citation Analysis]
118 Ehrengruber MU, Hennou S, Büeler H, Naim HY, Déglon N, Lundstrom K. Gene Transfer into Neurons from Hippocampal Slices: Comparison of Recombinant Semliki Forest Virus, Adenovirus, Adeno-Associated Virus, Lentivirus, and Measles Virus. Molecular and Cellular Neuroscience 2001;17:855-71. [DOI: 10.1006/mcne.2001.0982] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 4.3] [Reference Citation Analysis]
119 Malik JM, Shevtsova Z, Bähr M, Kügler S. Long-term in vivo inhibition of CNS neurodegeneration by Bcl-XL gene transfer. Mol Ther 2005;11:373-81. [PMID: 15727933 DOI: 10.1016/j.ymthe.2004.11.014] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 3.8] [Reference Citation Analysis]
120 Wang Y, Rajala A, Cao B, Ranjo-Bishop M, Agbaga MP, Mao C, Rajala RV. Cell-Specific Promoters Enable Lipid-Based Nanoparticles to Deliver Genes to Specific Cells of the Retina In Vivo. Theranostics 2016;6:1514-27. [PMID: 27446487 DOI: 10.7150/thno.15230] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
121 Castro MG, Williams JC, Southgate TD, Smith-arica J, Stone D, Hurtado-lorenzo A, Umana P, Lowenstein PR. Cell Type Specific and Inducible Transgenesis in the Anterior Pituitary Gland. In: Castro MG, editor. Transgenic Models in Endocrinology. Boston: Springer US; 2001. pp. 233-56. [DOI: 10.1007/978-1-4615-1633-0_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]